Ajooni Biotech Secures ₹250 Million Dairy Order, Stock Jumps 12%

Mumbai, August 26, 2025: Ajooni Biotech Ltd (NSE: AJOONI) reported it has secured a ₹250 million order from one of India’s top dairy cooperatives. The announcement fueled market sentiment with buy orders more than outweighing sell orders on the NSE.

Ajooni Biotech Share Price Update

At 12:38 PM IST, Ajooni Biotech’s shares price are at ₹5.66, an increase of 11.2% from the last close. The stock declined 26% over the last year, dipped 30% in year-to-date periods, but rose 2.9% in the last month and 7.6% in the last five sessions.

The stock for the day opened at ₹5.10, rose to an intraday high of ₹5.94, and fell to an intraday low of ₹5.09. The market capitalisation of the company is now at ₹98.01 crore. The stock has a P/E ratio of 28.30, which reflects the way the market perceives its earnings. The stock traded in the range of 52-week high of ₹10.34 and 52-week low of ₹5.01 in the last 12 months.

Landmark Dairy Order

The firm announced that it had secured a ₹250 million order from India’s leading dairy cooperative for the supply of high-quality cattle feed. Ajooni Biotech emphasized that the order is from a repeat customer, evidencing sustained faith in its products. The feed is custom-designed to enhance livestock health and increase milk output.

New Plant to Increase Capacity

In addition to this agreement, the company also announced progress on its new factory in Punjab, which is expected to be up and running by November 2025. The factory will have an annual capacity of producing 120,000 MT of cattle feed and will incorporate advanced technology to enhance efficiency, reduce costs, and accelerate revenue growth.

REF: https://nsearchives.nseindia.com/corporate/AJOONI_26082025112054_AJOONI__UpdateNSE_250_million_sd.pdf

Disclaimer:  At HDFC SKY, we take utmost care and due diligence in curating and presenting news and market-related content. However, inadvertent errors or omissions may occasionally occur.

If you have any concerns, questions, or wish to point out any discrepancies in our content, please feel free to write to us at content@hdfcsec.com.

Please note that the information shared is intended solely for informational purposes and does not make any investment recommendations